De Crescenzo F

Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.

1 paper

ArticlePsychedelics

Safety and Efficacy of the NMDA-2b-Selective Negative Allosteric Modulator BI 1569912: A Phase Ib Randomized Trial in Major Depressive Disorder.

McIntyre RS, Sanacora G, Walling DP +7